GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Issuance of Stock

LTR Pharma (ASX:LTP) Issuance of Stock : A$1.45 Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Issuance of Stock?

LTR Pharma's Issuance of Stock for the six months ended in Jun. 2023 was A$1.45 Mil.

LTR Pharma's Issuance of Stock for the trailing twelve months (TTM) ended in Jun. 2023 was A$1.45 Mil.

LTR Pharma Issuance of Stock Historical Data

The historical data trend for LTR Pharma's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Issuance of Stock Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
Issuance of Stock
0.10 2.34 1.45

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
Issuance of Stock 0.10 2.34 1.45

LTR Pharma Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Issuance of Stock for the trailing twelve months (TTM) ended in Jun. 2023 was A$1.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Issuance of Stock Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Issuance of Stock
Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
Website
https://www.ltrpharma.com
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines